Recital 255, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

The Commission further found that the Initial Commitments replicate the

competitive constraint currently exercised by Chr. Hansen as they include the G2 Project and the associated R&D staff which should allow a suitable purchaser to enter the lactase manufacturing market within a period of [time period] and compete against the Parties’ retained lactase manufacturing business.